CHEMVET PHARMA ApS: Financial statements 2024
CVR: 20386908
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
CHEMVET PHARMA ApS (CVR 20386908) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,464,494 and a net result of DKK 807,613 compared with DKK 516,720 the year before. That is an increase of 64.3% compared with the year before. Equity in the 2024 report amounted to DKK 3,101,907. The solvency ratio was 85.1%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,464,494
- Profit/Loss
- DKK 807,613
- Equity
- DKK 3,101,907
- Total Assets
- DKK 3,647,030
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 1.5M | 808K | 3.1M | 1 |
| 2023 | - | 892K | 517K | 2.3M | 1 |
| 2022 | - | 251K | -312K | 1.8M | 2 |
| 2021 | - | 317K | -477K | 2.1M | 2 |
| 2020 | - | 712K | 14K | 2.6M | 2 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
CHEMVET PHARMA ApS has published its annual report for 2023. Gross profit came to DKK 891,532, and the net result was DKK 516,720.
About CHEMVET PHARMA ApS
CHEMVET PHARMA ApS is a Danish company of the type Anpartsselskab based in Silkeborg, founded in 1997. The company is registered under the industry Engroshandel med andre fødevarer. The company was previously named ApS KBIL 9 NR. 2027. The management consists of Frank Arvé Christensen. The board consists of Sarah Arvé (chair), Frank Arvé Christensen and Maria Arvé Brostrøm. The company is owned by Frank Arvé Christensen, Sarah Arvé and Maria Arvé Brostrøm. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,700,759 and a net result of DKK 970,939 compared with DKK 807,613 the year before. Equity in the 2025 report amounted to DKK 3,822,846.